|
Q3 FY2018
As of Sep 30, 2018
|
Q2 FY2018
As of Jun 30, 2018
|
Q1 FY2018
As of Mar 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
Q3 FY2017
As of Sep 30, 2017
|
Q2 FY2017
As of Jun 30, 2017
|
Q1 FY2017
As of Mar 31, 2017
|
Q4 FY2016
As of Dec 31, 2016
|
Q3 FY2016
As of Sep 30, 2016
|
Q2 FY2016
As of Jun 30, 2016
|
Q1 FY2016
As of Mar 31, 2016
|
Q4 FY2015
As of Dec 31, 2015
|
Q3 FY2015
As of Sep 30, 2015
|
Q2 FY2015
As of Jun 30, 2015
|
Q1 FY2015
As of Mar 31, 2015
|
Q4 FY2014
As of Dec 31, 2014
|
Q3 FY2014
As of Sep 30, 2014
|
Q2 FY2014
As of Jun 30, 2014
|
Q1 FY2014
As of Mar 31, 2014
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current assets | |||||||||||||||||||
| Cash and cash equivalents | |||||||||||||||||||
| Short-term investments | |||||||||||||||||||
| Assets held for sale | |||||||||||||||||||
| Prepaid expenses | |||||||||||||||||||
| Deferred financing costs | |||||||||||||||||||
| Other receivables | |||||||||||||||||||
| Total current assets | |||||||||||||||||||
| Property and equipment, net | |||||||||||||||||||
| Restricted cash | |||||||||||||||||||
| Other assets | |||||||||||||||||||
| Total assets | |||||||||||||||||||
| Current liabilities | |||||||||||||||||||
| Accounts payable | |||||||||||||||||||
| Accrued expenses | |||||||||||||||||||
| Current portion of restructuring obligation | |||||||||||||||||||
| Notes payable | |||||||||||||||||||
| Current portion of other convertible notes | |||||||||||||||||||
| Current portion of manufacturing research and development obligation | |||||||||||||||||||
| Current portion of lease obligations | |||||||||||||||||||
| Power Generation Agreements | |||||||||||||||||||
| Lease Agreement | |||||||||||||||||||
| Total current portion of lease obligations | |||||||||||||||||||
| Total current liabilities | |||||||||||||||||||
| Convertible note payable to related party | |||||||||||||||||||
| Long-term portion of other convertible notes | |||||||||||||||||||
| Long-term portion of notes payable | |||||||||||||||||||
| Long-term portion of manufacturing research and development obligation | |||||||||||||||||||
| Long-term portion of lease obligations | |||||||||||||||||||
| Power Generation Agreements | |||||||||||||||||||
| Lease Agreement | |||||||||||||||||||
| Total long-term portion of lease obligations | |||||||||||||||||||
| Deferred liabilities | |||||||||||||||||||
| Warrants | |||||||||||||||||||
| Stockholders’ deficit | |||||||||||||||||||
| Preferred stock $0.001 par value; 5,000,000 shares authorized as of December 31, 2017 and September 30, 2018; 0 shares issued and outstanding as of December 31, 2017 and September 30, 2018 | |||||||||||||||||||
| Common stock $0.001 par value; 200,000,000 shares authorized as of December 31, 2017 and September 30, 2018; 5,906,620 and 10,586,661 shares issued and outstanding as of December 31, 2017 and September 30, 2018 | |||||||||||||||||||
| Accumulated other comprehensive loss | |||||||||||||||||||
| Additional paid-in capital | |||||||||||||||||||
| Accumulated deficit | |||||||||||||||||||
| Total stockholders’ deficit | |||||||||||||||||||
| Total liabilities and stockholders’ deficit | |||||||||||||||||||
Loading...
